ID   SP2_ANOGA               Reviewed;         409 AA.
AC   Q7QIJ8; Q005N3;
DT   07-APR-2021, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 4.
DT   28-JAN-2026, entry version 129.
DE   RecName: Full=Serine protease inhibitor 2 {ECO:0000303|PubMed:19394412};
DE            Short=Serpin 2 {ECO:0000303|PubMed:19394412};
DE   Flags: Precursor;
GN   Name=SRPN2 {ECO:0000303|PubMed:19394412}; Synonyms=1270169;
GN   ORFNames=AgaP_AGAP006911 {ECO:0000312|EMBL:EAA04043.4};
OS   Anopheles gambiae (African malaria mosquito).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Nematocera; Culicoidea; Culicidae;
OC   Anophelinae; Anopheles.
OX   NCBI_TaxID=7165 {ECO:0000312|Proteomes:UP000007062};
RN   [1] {ECO:0000312|EMBL:ABJ52801.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DEVELOPMENTAL STAGE.
RX   PubMed=19394412; DOI=10.1016/j.gene.2009.04.013;
RA   Suwanchaichinda C., Kanost M.R.;
RT   "The serpin gene family in Anopheles gambiae.";
RL   Gene 442:47-54(2009).
RN   [2] {ECO:0000312|Proteomes:UP000007062}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=PEST {ECO:0000312|Proteomes:UP000007062};
RX   PubMed=12364791; DOI=10.1126/science.1076181;
RA   Holt R.A., Subramanian G.M., Halpern A., Sutton G.G., Charlab R.,
RA   Nusskern D.R., Wincker P., Clark A.G., Ribeiro J.M.C., Wides R.,
RA   Salzberg S.L., Loftus B.J., Yandell M.D., Majoros W.H., Rusch D.B., Lai Z.,
RA   Kraft C.L., Abril J.F., Anthouard V., Arensburger P., Atkinson P.W.,
RA   Baden H., de Berardinis V., Baldwin D., Benes V., Biedler J., Blass C.,
RA   Bolanos R., Boscus D., Barnstead M., Cai S., Center A., Chaturverdi K.,
RA   Christophides G.K., Chrystal M.A.M., Clamp M., Cravchik A., Curwen V.,
RA   Dana A., Delcher A., Dew I., Evans C.A., Flanigan M.,
RA   Grundschober-Freimoser A., Friedli L., Gu Z., Guan P., Guigo R.,
RA   Hillenmeyer M.E., Hladun S.L., Hogan J.R., Hong Y.S., Hoover J.,
RA   Jaillon O., Ke Z., Kodira C.D., Kokoza E., Koutsos A., Letunic I.,
RA   Levitsky A.A., Liang Y., Lin J.-J., Lobo N.F., Lopez J.R., Malek J.A.,
RA   McIntosh T.C., Meister S., Miller J.R., Mobarry C., Mongin E., Murphy S.D.,
RA   O'Brochta D.A., Pfannkoch C., Qi R., Regier M.A., Remington K., Shao H.,
RA   Sharakhova M.V., Sitter C.D., Shetty J., Smith T.J., Strong R., Sun J.,
RA   Thomasova D., Ton L.Q., Topalis P., Tu Z.J., Unger M.F., Walenz B.,
RA   Wang A.H., Wang J., Wang M., Wang X., Woodford K.J., Wortman J.R., Wu M.,
RA   Yao A., Zdobnov E.M., Zhang H., Zhao Q., Zhao S., Zhu S.C., Zhimulev I.,
RA   Coluzzi M., della Torre A., Roth C.W., Louis C., Kalush F., Mural R.J.,
RA   Myers E.W., Adams M.D., Smith H.O., Broder S., Gardner M.J., Fraser C.M.,
RA   Birney E., Bork P., Brey P.T., Venter J.C., Weissenbach J., Kafatos F.C.,
RA   Collins F.H., Hoffman S.L.;
RT   "The genome sequence of the malaria mosquito Anopheles gambiae.";
RL   Science 298:129-149(2002).
RN   [3] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16113656; DOI=10.1038/sj.embor.7400478;
RA   Michel K., Budd A., Pinto S., Gibson T.J., Kafatos F.C.;
RT   "Anopheles gambiae SRPN2 facilitates midgut invasion by the malaria
RT   parasite Plasmodium berghei.";
RL   EMBO Rep. 6:891-897(2005).
RN   [4] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH CLIPB9, SUBCELLULAR LOCATION, AND DISRUPTION
RP   PHENOTYPE.
RC   STRAIN=G3 {ECO:0000269|PubMed:20953892};
RX   PubMed=20953892; DOI=10.1007/s00018-010-0543-z;
RA   An C., Budd A., Kanost M.R., Michel K.;
RT   "Characterization of a regulatory unit that controls melanization and
RT   affects longevity of mosquitoes.";
RL   Cell. Mol. Life Sci. 68:1929-1939(2011).
RN   [5]
RP   FUNCTION, INTERACTION WITH CLIPB10, AND DISRUPTION PHENOTYPE.
RC   STRAIN=G3 {ECO:0000269|PubMed:33520733};
RX   PubMed=33520733; DOI=10.3389/fcimb.2020.585986;
RA   Zhang X., Li M., El Moussawi L., Saab S., Zhang S., Osta M.A., Michel K.;
RT   "CLIPB10 is a Terminal Protease in the Regulatory Network That Controls
RT   Melanization in the African Malaria Mosquito Anopheles gambiae.";
RL   Front. Cell. Infect. Microbiol. 10:585986-585986(2020).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=G3 {ECO:0000269|PubMed:33045027};
RX   PubMed=33045027; DOI=10.1371/journal.ppat.1008985;
RA   Sousa G.L., Bishnoi R., Baxter R.H.G., Povelones M.;
RT   "The CLIP-domain serine protease CLIPC9 regulates melanization downstream
RT   of SPCLIP1, CLIPA8, and CLIPA28 in the malaria vector Anopheles gambiae.";
RL   PLoS Pathog. 16:e1008985-e1008985(2020).
RN   [7]
RP   FUNCTION, INTERACTION WITH CLIPB4, AND DISRUPTION PHENOTYPE.
RX   PubMed=37703846; DOI=10.1159/000533898;
RA   Zhang X., Zhang S., Kuang J., Sellens K.A., Morejon B., Saab S.A., Li M.,
RA   Metto E.C., An C., Culbertson C.T., Osta M.A., Scoglio C., Michel K.;
RT   "CLIPB4 Is a Central Node in the Protease Network that Regulates Humoral
RT   Immunity in Anopheles gambiae Mosquitoes.";
RL   J. Innate Immun. 15:680-696(2023).
RN   [8] {ECO:0007744|PDB:3PZF}
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 22-409.
RX   PubMed=21465556; DOI=10.1002/prot.23002;
RA   An C., Lovell S., Kanost M.R., Battaile K.P., Michel K.;
RT   "Crystal structure of native Anopheles gambiae serpin-2, a negative
RT   regulator of melanization in mosquitoes.";
RL   Proteins 79:1999-2003(2011).
RN   [9] {ECO:0007744|PDB:4RO9, ECO:0007744|PDB:4ROA, ECO:0007744|PDB:4ROB, ECO:0007744|PDB:4RSQ}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 22-409 OF MUTANTS CYS-198;
RP   GLU-368; TRP-358 AND CYS-359, FUNCTION, INTERACTION WITH CLIPB9,
RP   PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS OF LYS-198; SER-358 AND GLU-359.
RX   PubMed=25525260; DOI=10.1074/jbc.m114.625665;
RA   Zhang X., Meekins D.A., An C., Zolkiewski M., Battaile K.P., Kanost M.R.,
RA   Lovell S., Michel K.;
RT   "Structural and inhibitory effects of hinge loop mutagenesis in serpin-2
RT   from the malaria vector Anopheles gambiae.";
RL   J. Biol. Chem. 290:2946-2956(2015).
CC   -!- FUNCTION: Serine protease inhibitor that functions in the melanization-
CC       mediated immune response (PubMed:16113656, PubMed:20953892,
CC       PubMed:21465556, PubMed:25525260, PubMed:33045027, PubMed:33520733). By
CC       preventing the activation of phenoloxidases through the inhibiting of
CC       serine proteases CLIPB9, CLIPB10 and CLIPB4, negatively regulates
CC       melanization in the hemolymph (PubMed:16113656, PubMed:20953892,
CC       PubMed:21465556, PubMed:25525260, PubMed:33045027, PubMed:33520733,
CC       PubMed:37703846). By preventing melanization, has a detrimental role
CC       during P.berghei parasite mediated-infection and invasion of the
CC       mosquito midgut (PubMed:16113656). {ECO:0000269|PubMed:16113656,
CC       ECO:0000269|PubMed:20953892, ECO:0000269|PubMed:21465556,
CC       ECO:0000269|PubMed:25525260, ECO:0000269|PubMed:33045027,
CC       ECO:0000269|PubMed:33520733, ECO:0000269|PubMed:37703846}.
CC   -!- SUBUNIT: Forms a covalent heterodimer with protease CLIPB9; the
CC       interaction inhibits CLIPB9 protease activity (PubMed:20953892,
CC       PubMed:25525260). Forms a covalent heterodimer with protease CLIPB10;
CC       the interaction inhibits CLIPB10 catalytic activity (PubMed:33520733).
CC       Interacts with CLIPB4 in the hemolymph of immune-challenged female
CC       mosquitoes; the interaction results in CLIPB4 inhibition
CC       (PubMed:37703846). {ECO:0000269|PubMed:20953892,
CC       ECO:0000269|PubMed:25525260, ECO:0000269|PubMed:33520733,
CC       ECO:0000269|PubMed:37703846}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:16113656}.
CC       Note=Secreted into the hemolymph. {ECO:0000269|PubMed:16113656,
CC       ECO:0000269|PubMed:20953892}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in embryos, larvae, pupae, and female
CC       and male adults. {ECO:0000269|PubMed:19394412}.
CC   -!- PTM: Protease CLIPB9 binds to SRPN2 via the hinge region resulting in
CC       the cleavage of the reactive bond (PubMed:25525260). This leads to a
CC       conformational change in SRPN2 which traps CLIPB9 and distorts its
CC       active site, resulting in CLIPB9 inactivation (PubMed:25525260).
CC       {ECO:0000269|PubMed:25525260}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown in female causes
CC       spontaneous melanization leading to the formation of melanotic
CC       pseudotumors and a shortening of lifespan; spontaneous melanization is
CC       reduced in double SRPN2/CLIPB9, SRPN2/CLIPB10 and SRPN2/CLIPB4 mutant
CC       backgrounds (PubMed:16113656, PubMed:20953892, PubMed:33520733,
CC       PubMed:37703846). During the mosquito midgut infection by the rodent
CC       malaria parasite P.berghei, severely reduces oocyst numbers due to an
CC       increase in ookinete lysis and melanization (PubMed:16113656). Does not
CC       affect ookinete formation (PubMed:16113656). Causes proteolytic
CC       cleavage of CLIPA28 and CLIPC9 in absence of E.coli infection
CC       (PubMed:33045027). {ECO:0000269|PubMed:16113656,
CC       ECO:0000269|PubMed:20953892, ECO:0000269|PubMed:33045027,
CC       ECO:0000269|PubMed:33520733, ECO:0000269|PubMed:37703846}.
CC   -!- SIMILARITY: Belongs to the serpin family.
CC       {ECO:0000255|RuleBase:RU000411}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ974161; ABJ52801.1; -; mRNA.
DR   EMBL; AAAB01008807; EAA04043.4; -; Genomic_DNA.
DR   PDB; 3PZF; X-ray; 1.75 A; A=22-409.
DR   PDB; 4RO9; X-ray; 2.00 A; A/B/C=22-409.
DR   PDB; 4ROA; X-ray; 1.90 A; A=22-409.
DR   PDB; 4ROB; X-ray; 2.80 A; A/B/C=22-409.
DR   PDB; 4RSQ; X-ray; 2.90 A; A/B/C/D/E/F/G/H/I/J/K/L=22-409.
DR   PDBsum; 3PZF; -.
DR   PDBsum; 4RO9; -.
DR   PDBsum; 4ROA; -.
DR   PDBsum; 4ROB; -.
DR   PDBsum; 4RSQ; -.
DR   AlphaFoldDB; Q7QIJ8; -.
DR   SMR; Q7QIJ8; -.
DR   FunCoup; Q7QIJ8; 36.
DR   STRING; 7165.Q7QIJ8; -.
DR   MEROPS; I04.070; -.
DR   GlyCosmos; Q7QIJ8; 2 sites, No reported glycans.
DR   PaxDb; 7165-AGAP006911-PA; -.
DR   EnsemblMetazoa; AGAMI1_006884.R13329; AGAMI1_006884.P13329; AGAMI1_006884.
DR   EnsemblMetazoa; AGAP006911-RA; AGAP006911-PA; AGAP006911.
DR   GeneID; 1270169; -.
DR   KEGG; aga:1270169; -.
DR   VEuPathDB; VectorBase:AGAMI1_006884; -.
DR   VEuPathDB; VectorBase:AGAP006911; -.
DR   eggNOG; KOG2392; Eukaryota.
DR   HOGENOM; CLU_023330_0_1_1; -.
DR   InParanoid; Q7QIJ8; -.
DR   OMA; VKSAQWA; -.
DR   PhylomeDB; Q7QIJ8; -.
DR   EvolutionaryTrace; Q7QIJ8; -.
DR   Proteomes; UP000007062; Chromosome 2L.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0042832; P:defense response to protozoan; IDA:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0010951; P:negative regulation of endopeptidase activity; IMP:UniProtKB.
DR   GO; GO:0035009; P:negative regulation of melanization defense response; IDA:UniProtKB.
DR   GO; GO:0010955; P:negative regulation of protein processing; IMP:UniProtKB.
DR   GO; GO:0045861; P:negative regulation of proteolysis; IDA:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; IBA:GO_Central.
DR   CDD; cd19578; serpinK_insect_SRPN2-like; 1.
DR   FunFam; 2.30.39.10:FF:000030; Serpin 2; 3.
DR   Gene3D; 2.30.39.10; Alpha-1-antitrypsin, domain 1; 2.
DR   Gene3D; 3.30.497.10; Antithrombin, subunit I, domain 2; 1.
DR   InterPro; IPR023795; Serpin_CS.
DR   InterPro; IPR023796; Serpin_dom.
DR   InterPro; IPR000215; Serpin_fam.
DR   InterPro; IPR036186; Serpin_sf.
DR   InterPro; IPR042178; Serpin_sf_1.
DR   InterPro; IPR042185; Serpin_sf_2.
DR   PANTHER; PTHR11461:SF357; SERINE PROTEASE INHIBITOR 27A; 1.
DR   PANTHER; PTHR11461; SERINE PROTEASE INHIBITOR, SERPIN; 1.
DR   Pfam; PF00079; Serpin; 1.
DR   SMART; SM00093; SERPIN; 1.
DR   SUPFAM; SSF56574; Serpins; 1.
DR   PROSITE; PS00284; SERPIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Glycoprotein; Immunity; Innate immunity; Protease inhibitor;
KW   Reference proteome; Secreted; Serine protease inhibitor; Signal.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..409
FT                   /note="Serine protease inhibitor 2"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5014588544"
FT   MOTIF           356..360
FT                   /note="Hinge region; required for binding to peptidase"
FT                   /evidence="ECO:0000269|PubMed:25525260"
FT   SITE            371..372
FT                   /note="Reactive bond"
FT                   /evidence="ECO:0000305|PubMed:25525260"
FT   CARBOHYD        294
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        324
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   MUTAGEN         198
FT                   /note="K->C: 6.7-fold reduction in CLIPB9 inhibition
FT                   without affecting the interaction with CLIPB9; when
FT                   associated with C-359."
FT                   /evidence="ECO:0000269|PubMed:25525260"
FT   MUTAGEN         358
FT                   /note="S->E: 3-fold increase in peptidase CLIPB9
FT                   inhibition. Does not affect interaction with CLIPB9."
FT                   /evidence="ECO:0000269|PubMed:25525260"
FT   MUTAGEN         358
FT                   /note="S->W: Inhibits interaction with CLIPB9 but does not
FT                   inhibit CLIPB9 peptidase activity. Cleavage of SRNP2 by
FT                   CLIPB9 is not affected."
FT                   /evidence="ECO:0000269|PubMed:25525260"
FT   MUTAGEN         359
FT                   /note="E->C: 6.7-fold reduction in CLIPB9 inhibition
FT                   without affecting the interaction with CLIPB9; when
FT                   associated with C-198."
FT                   /evidence="ECO:0000269|PubMed:25525260"
FT   CONFLICT        5..7
FT                   /note="NFV -> SFL (in Ref. 1; ABJ52801)"
FT                   /evidence="ECO:0000305"
FT   HELIX           36..47
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   HELIX           57..70
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   HELIX           72..74
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   HELIX           81..85
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   HELIX           86..89
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   HELIX           95..110
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          117..127
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   HELIX           134..144
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          146..151
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   HELIX           156..170
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   TURN            171..173
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   HELIX           181..184
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          188..203
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          212..215
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          218..221
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          223..239
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   TURN            240..243
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          244..251
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          254..263
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   HELIX           269..275
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   HELIX           278..286
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          289..298
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          300..308
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   HELIX           309..314
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   HELIX           319..321
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          322..324
FT                   /evidence="ECO:0007829|PDB:4RSQ"
FT   TURN            328..330
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          344..353
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          355..359
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          378..381
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          386..392
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   TURN            393..395
FT                   /evidence="ECO:0007829|PDB:3PZF"
FT   STRAND          398..406
FT                   /evidence="ECO:0007829|PDB:3PZF"
SQ   SEQUENCE   409 AA;  46512 MW;  37636C90AFA2D7F0 CRC64;
     MNKLNFVILC LAALLVFDAT AQQDVHGPFQ GQRQNEFDLM FVKEIFKNHN SNVVLSPFSV
     KILLTLIYEA SDTSFGNAVS NTKRELSSVI QNDNIDHTRS YYKQLLESAQ QDNKDYDLNI
     ATNFFVDDFI EVINKYQQIA NTHYHAMLEK VSYSNPTQTA ATINNWVSEH TNGRLREIVT
     PDSLEGAVIT LVNVIYFKGL WTYPFPEVAN NVKPFYGTRG KPTNAQYMEQ NGQFYYDNSA
     DLGAQILRLP YRGNKLAMYF ILPNPDNTVN QVLDRINSAS LHQALWYMEE NEVNVTLPKF
     KFDFSEQLNE PLQQVGIREI FSQNASLPLL ARGRGARDEV RVSRIFQKAG ITINELGSEA
     YAATEIQLVN KFGGDGVQIF NANRPFIFFI EDETLGTMLF AGKIENPVF
//
